Product Information
PAROXETINE ER 37.5 MG TABLET is a generic product labeled by Lannett Company Inc., priced at $0.4279 per EA under NDC 62175047232. Its NADAC has been published 511 times since Sep 14, 2016.
Strength
37.5 mg/1
Manufacturer
Lannett Company Inc.NDC
62175047232
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PAROXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204744On Market Since
10/31/2014
Pharmacological Classes
Price Statistics
The NADAC for PAROXETINE ER 37.5 MG TABLET has been published 511 times since Sep 14, 2016, and over the history we have for it it has declined 90.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4279 per EA |
|---|---|
| All-time high | $4.6624 (Nov 16, 2016) |
| All-time low | $0.3671 (Nov 20, 2024) |
| 52-week high | $0.5530 |
| 52-week low | $0.4047 |
| Median price | $1.1608 |
| Average price | $1.6789 |
| Largest weekly change | +50.9% (Feb 22, 2023) |
| Weeks tracked | 511 |
| Tracking since | Sep 14, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Paroxetine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PAROXETINE ER 37.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE ER 37.5 MG TABLET, manufactured by Lannett Company Inc., is $0.4279 per EA (NDC 62175047232), effective Jun 24, 2026.
How has the price of PAROXETINE ER 37.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAROXETINE ER 37.5 MG TABLET has declined 90.5%. It has been tracked across 511 weekly CMS publications since Sep 14, 2016.
What are the highest and lowest recorded NADAC prices for PAROXETINE ER 37.5 MG TABLET?
Since Sep 14, 2016, the NADAC for PAROXETINE ER 37.5 MG TABLET has ranged from a low of $0.3671 (Nov 20, 2024) to a high of $4.6624 (Nov 16, 2016), with a median of $1.1608 per EA.
Are there cheaper alternatives to PAROXETINE ER 37.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PAROXETINE ER 37.5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures PAROXETINE ER 37.5 MG TABLET?
PAROXETINE ER 37.5 MG TABLET (NDC 62175047232) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification